CPSCCPSC · Productos de consumo·N.º oficial 26157
Mamisan Pain Relieving Topical Ointment
Publicado el 18 de diciembre de 2025 · Inicio del retiro: 18 de diciembre de 2025
Qué peligro representa
The ointment contains lidocaine, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The ointment's packaging is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are swallowed by young children.
Qué hacer
Consumers should immediately secure the recalled ointment jars out of the sight and reach of children and contact Plantimex to receive a free replacement lid. Once the product is secured with the replacement lid, consumers can use the product, as directed.
Detalles del retiro
- Marca
- MiramarLab, of Doral, Florida
- Fabricante
- MiramarLab, of Doral, Florida
- Distribuidor
- Plantimex Distributors, Inc., of San Diego, California
- UPC
- 860006498115
- País
- US
¿Vendes productos como este?
Recalert vigila todo tu catálogo contra retiros como este, automáticamente.